A Clinical Study to assess the add on effect of siravedh followed by vipadikahar lepa in vipadika

A RANDOMIZED OPEN CONTROLLED CLINICAL STUDY TO ASSESS THE ADD ON EFFECT OF SIRAVEDH FOLLOWED BY VIPADIKAHAR LEPA IN VIPADIKA W.S.R PALMOPLANTAR PSORIASIS - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106866

Enrollment

Registered

2026-03-24

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L408- Other psoriasis

Interventions

Intervention1: lepa: vipadikahar lepa mentioned on vipadika in bhaishyajya ratnavali. by local application of vipadikahar lepa width 0.5cm twice a day for 15 days Control Intervention1: NIL: NIL Cont

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient presenting complaint of vipadika, vedana,dah,sphutana 2. Patient will be selected irrespective og gender,religion or occupation 3. Age between 18-60 years 4. Patient willing to give inform consent and able to participate in study 5. Patient fir for siravedh

Exclusion criteria

Exclusion criteria: 1. Patient on medication of anticoagulant 2. Patients with hemophilic disorders

Design outcomes

Primary

Measure	Time frame
To study the add on effect of siravedh followed by vipadikahar lepa in vipadikaTimepoint: 15 days	—

Secondary

Measure	Time frame
To study thr reduce symptoms of vipadika kushtha like vedana,daha according to ayurveda To improve quality of life & reduce discomfort of patientsTimepoint: 15 days	—

Countries

India

Contacts

Public ContactDr Lalitkumar sharadrao Patil

Yashwant Ayurvedic College Post Graduate Training And Reserch Centre Kodoli

abhijeetingavale@gmail.com9822919000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026